Background Inhaled hypertonic saline (HTS) improves quality of life and reduces pulmonary exacerbations when given long term in patients with cystic fibrosis (CF). While increasingly being offered for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback